Head-to-Head

Abbott Laboratories vs. Bristol-Myers Squibb Co.

ABT

Abbott Laboratories

$102.83 +0.58%

VS BMY

Bristol-Myers Squibb Co.

$62.84 -1.19%

Bristol-Myers Squibb Co. (BMY) comes out ahead, leading on 9 of 11 compared factors.

Size & Scale

ABTBMY
Market Cap $176.90 billion $129.92 billion
Revenue (TTM) $46.59 billion $49.19 billion
Net Income (TTM) $5.42 billion $9.27 billion

BMY leads on 2 of 3 size & scale factors.

Valuation

ABTBMY
P/E Ratio 33.28 13.84
Price / Book 3.42 5.82
Price / Sales 3.80 2.64

BMY leads on 2 of 3 valuation factors.

Profitability

ABTBMY
Net Margin 11.65% 18.85%
Return on Equity 10.48% 41.55%

BMY leads on 2 of 2 profitability factors.

Dividend

ABTBMY
Dividend Yield 2.45% 4.01%
Payout Ratio 81.55 55.51

BMY leads on 2 of 2 dividend factors.

Risk & Sentiment

ABTBMY
Short Interest 0.57% 0.39%

BMY leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, BMY overview, BMY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.